This course focuses on Meibomian Gland Dysfunction (MGD), exploring its definition, pathophysiology, and prevalence, alongside practical diagnostic techniques such as gland expression and meibography, enhanced by video presentations. Participants will learn to integrate these diagnostics into practice, understanding the importance of assessing both the structure and function of meibomian glands for improved patient outcomes.
This activity, COPE Activity Number 128066, is accredited by COPE for continuing education for optometrists.
COPE Course No.: 90120-TD
Release Date: 03-29-2024
Expiration Date: 03-28-2024
Grant Support Statement
This activity is supported by unrestricted educational grants from Alcon, Horizon Therapeutics, SightSciences, and Tarsus Pharmaceuticals, Inc.
Marc Bloomenstein, OD, FAAO
Director of Optometric Services
Doug Devries, OD
Director and Managing Partner